lung cancer gene and literature database Home
Cancer metastasis database

Annotation category 5

Literatures

Literature evidence

Links to all GeneRIF Items

5315

PubMed (Gene Name)

Literature evidence

12820320 (PKM)

With the fuzzy logic method and a tumor marker panel (including the new marker tumor M2-PK), a useful diagnostic tool for the detection of progression in lung cancer patients is available

22052977 (PKM)

findings show, in lung cancer cells, increases in intracellular ROS caused inhibition of PKM2 through oxidation of Cys(358);regulatory properties of PKM2 may confer an additional advantage to cancer cells by allowing them to withstand oxidative stress

25233397 (PKM)

High PKM2 levels were associated with low platinum sensitivity in metastatic non-small-cell lung cancer.

25444918 (PKM)

High Pyruvate Kinase, M2-Type expression is associated with low radiosensitivity in non-small cell lung cancer.

26140362 (PKM)

purine biosynthetic pathway enzymes PPAT and PAICS, as well as pyruvate kinase activity are increased in lung cancer

28259998 (PKM)

Study shows that the enhanced expression of PKM2 in lung cancer cells is likely associated with the biological properties of cancer stem cells.

28418088 (PKM)

It has been found that the adaptor protein receptor for activated PKC kinase (RACK1) formed a complex with FGFR1 and PKM2, and activated the FGFR1/PKM2 signaling. The study shows that RACK1 forms a complex with FGFR1 and PKM2, and stimulates the growth and migration of squamous lung cancer cells.

28489603 (PKM)

High PKM2 expression is associated with lung adenocarcinoma.

28641694 (PKM)

Overexpression of miR-133b inhibited the growth and proliferation of lung cancer stem cells by down regulating PKM2.

28778925 (PKM)

Data suggest that PKM1 and PKM2, alternative splice variants that interact with each other, are expressed and localized differently in lung carcinoma cell lines; PKM1 or PKM2 knockdown (via RNA interference) differentially affects net pyruvate kinase activity, mitochondrial biogenesis, energy metabolism, ATP level, autophagy, and apoptosis/cell viability.

30925904 (PKM)

PKM2 regulated PD-L1 expression and was associated with poor outcomes in lung adenocarcinoma patients.

31106485 (PKM)

Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells.

32049010 (PKM)

Secreted Pyruvate Kinase M2 Promotes lung cancer Metastasis through Activating the Integrin Beta1/FAK Signaling pathway.

32308748 (PKM)

Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1alpha axis.